High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy
about
The Hepatoprotective Effect of Haoqin Qingdan Decoction against Liver Injury Induced by a Chemotherapeutic Drug Cyclophosphamide18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulationGinseng alleviates cyclophosphamide-induced hepatotoxicity via reversing disordered homeostasis of glutathione and bile acid.Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma.Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation.A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-upHepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology GroupLow-dose cyclophosphamide-induced acute hepatotoxicity.Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.Peroxisome Proliferator Activator Receptor (PPAR)- γ Ligand, but Not PPAR- α , Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver.Pyrrolizidine alkaloids in food: a spectrum of potential health consequences.Gamma-Glutamylcysteine Ethyl Ester Protects against Cyclophosphamide-Induced Liver Injury and Hematologic Alterations via Upregulation of PPARγ and Attenuation of Oxidative Stress, Inflammation, and Apoptosis.Two difficulty diagnosis cases of severe veno-occlusive disease.Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation.Genistein Ameliorates Cyclophosphamide - Induced Hepatotoxicity by Modulation of Oxidative Stress and Inflammatory Mediators.Immunoassay approach for diagnosis of exposure to pyrrolizidine alkaloids.
P2860
Q35697810-A5D37550-7529-4937-9DCF-685B800179E3Q36074465-AB27F952-AE96-40D6-9F48-E217C7B7DA21Q36340043-F786A03C-3B2E-45BF-9C8B-63FE39E3F822Q36652629-6ECA7BFA-329D-4920-964C-9FBE61FFEBB2Q36949557-2D3EBAB7-8E51-4BD9-995D-19A0D27F32A6Q36970948-6C3B41DC-A355-4F67-888A-B590C97E4BE4Q36997723-D8B28EA0-D8C9-4C71-A7E4-71741CEE1CAEQ37001941-12A43294-5AEB-44AE-A2F0-F98989DF8F3CQ37120672-A2E4CF67-026B-459A-9E54-D9EF6F747928Q37157498-3A4417AA-5A3A-45D9-8962-1246CB5AB6EBQ37283147-6F3B5196-3D37-4036-9DF7-D866F6774020Q37717916-940C3560-74EF-4563-9E26-D7D75E9C3721Q37848258-DCCC2E6A-699D-4B39-9057-808C8F477903Q39028144-ECE9AC58-6346-4754-BA2C-AB92C6CEB2A4Q41988180-9CE8A239-9348-437A-B60B-26CF90F492B1Q46390723-3378C79D-083C-46DC-A78E-9DD7C0BEF7C9Q49809384-857346C2-198D-406A-A387-482C5B5F57EAQ50438002-32E3FD3E-9117-43DE-8635-57947F069584
P2860
High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
High exposures to bioactivated ...... llowing high-dose chemotherapy
@ast
High exposures to bioactivated ...... llowing high-dose chemotherapy
@en
type
label
High exposures to bioactivated ...... llowing high-dose chemotherapy
@ast
High exposures to bioactivated ...... llowing high-dose chemotherapy
@en
prefLabel
High exposures to bioactivated ...... llowing high-dose chemotherapy
@ast
High exposures to bioactivated ...... llowing high-dose chemotherapy
@en
P2093
P2860
P356
P1476
High exposures to bioactivated ...... llowing high-dose chemotherapy
@en
P2093
A D R Huitema
J H Beijnen
M E de Jonge
S Rodenhuis
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603097
P407
P577
2006-05-01T00:00:00Z